Acute Myelogenous Leukemia: Clinical Trials

2 trials for Acute Myelogenous Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Suspended 2
Phase 11Suspended 1

Follow Acute Myelogenous Leukemia: new trials by email Literature Review of Acute Myelogenous Leukemia trials Research Report on Acute Myelogenous Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Cyclophosphamide, Fludarabine, Thiotepa - Acute Myelogenous Leukemia, Acute Lymphatic Leukemia
Phase 2SuspendedLeland Metheny202026-04-082026-09-10
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Emavusertib, Venetoclax - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1 / Phase 2SuspendedCuris, Inc.3662020-07-062026-03-19

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Myelodysplastic Syndromes (2)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Chronic Disease (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)

Interventions

Abatacept (1)  ·  CA-4948 (1)  ·  Cyclophosphamide (1)  ·  Mycophenolic Acid (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine (1)  ·  venetoclax (1)

Sponsors

Curis, Inc. (1)  ·  Leland Metheny (1)

Countries

United States (2)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Leland Metheny, MD (1)